Altus Pharmaceuticals Inc. (ALTU) Chief Executive Officer, Sheldon Berkle to Ring The NASDAQ Stock Market Opening Bell

ADVISORY, Feb. 6, 2007 (PRIME NEWSWIRE) --

What: Sheldon Berkle, Chief Executive Officer of Altus Pharmaceuticals Inc. (ALTU) will preside over the opening bell to celebrate the Company's One Year Listing Anniversary on NASDAQ. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Wednesday, February 7, 2007 at 9:30 a.m. ET Contacts: John Jordan Senior Director, Corporate Communications Altus Pharmaceuticals, Inc. 617-299-2852 (office) 617-899-8112 (cell) NASDAQ MarketSite: Jolene Libretto; 646.441.5220; mobile - 347.219.9539 Jolene.Libretto@NASDAQ.com

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.

Webcast:

A live Webcast of the NASDAQ Opening Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Altus Pharmaceuticals Inc. (ALTU):

Altus was created in 1993 to research and refine our proprietary protein crystallization and cross-linking technology. Crystallization and cross-linking of proteins provide significant improvements in stability and concentration of proteins which leads to the opportunity for oral and parenteral delivery of proteins.

Today, Altus is building a robust pipeline of products to treat a number of serious medical conditions associated with chronic gastrointestinal and metabolic disease areas. Our vision is to be the worldwide leader in the rapid and efficient development of valuable orally-delivered and injectable protein replacement products to meet unmet medical needs.

In This Story

NDAQ